Cleveland GI Oncology Consortium Meeting is Doggone Successful

Dr. Gary Schwartz poses in front of the field at the Cleveland Browns Stadium

Presentations, collegial debates, networking, and a spirit of collaboration were the themes throughout the evening at the 2024 Cleveland Gastrointestinal (GI) Oncology Consortium Meeting planned jointly by cancer experts from University Hospitals (UH) and Cleveland Clinic (CCF) with support from the Case Comprehensive Cancer Center (Case CCC).

Meeting chairs Amit Mahipal, MD, MPH (UH) and Bassam Estfan, MD (CCF) arranged a robust schedule of speakers at the Cleveland Browns Stadium Lake Club. The event was attended by 190 people.

Gary Schwartz, Case CCC's Director, made introductory remarks and revealed that he spent his early years in practice as a GI oncologist.

Presentations were set up as mini-debates. Jordan Winter, MD (UH) and Daniel Joyce, MD (CCF) discussed the merits of neoadjuvant versus adjuvant therapy for resectable PDAC, moderated by Jeffrey Hardacre, MD (UH). Michelle Treasure, MD, from the Cleveland VA Medical Center, moderated the presentation titled Radiation: Is there a role in resectable and borderline resectable PDAC? featuring Jennifer Dorth, MD (UH) and Kanika Nair, MD (CCF).

Wen Wee Ma, MD (CCF) presented Non-chemotherapeutic options for PDAC followed by a case discussion by doctors David Bajor (UH), Lauren Henke (UH), Alok Khorana (CCF), Lee Ocuin (UH), and Robert Simon (CCF).

If you missed this week's event, don't worry. You will have another chance to attend the next joint consortium meeting in the coming year.